Dose adjustment in renal impairment
Dose adjustment may be needed in kidney disease.
Leaflet HEPAXANE 6000UI (60mg)/0.6ml solution for injection in pre-filled syringe
- Product code:
- W67315010
- Quantity:
- 50
- Indicated for:
- prevention and treatment of thromboembolism
- Route of administration:
- injectable
- Substance:
- enoxaparin (anticoagulant)
- ATC
- B01AB05 — Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Heparin group
Precautions:
Major drug interactions
This medicine may have important interactions with other medicines.
Additional monitoring
This medicine is subject to additional monitoring.
Breastfeeding warning
Use during breastfeeding only on medical advice.
Pregnancy warning
Use during pregnancy only on medical advice.
Bleeding risk
This medicine may increase the risk of bleeding.
Enoxaparin is an anticoagulant medication used to prevent and treat blood clots (thrombosis). It belongs to the class of low molecular weight heparins (LMWH) and works by inhibiting clotting factors, particularly thrombin and factor Xa, thereby preventing the formation of blood clots.
Enoxaparin is indicated for the prevention of deep vein thrombosis (DVT), pulmonary embolism (PE), and thrombotic complications in patients with unstable angina or non-ST-elevation myocardial infarction (NSTEMI). It is also used to treat existing thrombosis and to prevent clot formation in immobilized patients or those undergoing surgery.
The medication is administered as subcutaneous injections, usually in the abdominal area, as directed by a healthcare provider. Side effects may include bleeding, hematomas at the injection site, nausea, or, rarely, allergic reactions and heparin-induced thrombocytopenia (HIT). It is important to use enoxaparin as prescribed and to inform the healthcare provider about other medications or pre-existing conditions to avoid complications.
Enoxaparin is indicated for the prevention of deep vein thrombosis (DVT), pulmonary embolism (PE), and thrombotic complications in patients with unstable angina or non-ST-elevation myocardial infarction (NSTEMI). It is also used to treat existing thrombosis and to prevent clot formation in immobilized patients or those undergoing surgery.
The medication is administered as subcutaneous injections, usually in the abdominal area, as directed by a healthcare provider. Side effects may include bleeding, hematomas at the injection site, nausea, or, rarely, allergic reactions and heparin-induced thrombocytopenia (HIT). It is important to use enoxaparin as prescribed and to inform the healthcare provider about other medications or pre-existing conditions to avoid complications.
General data about HEPAXANE 6000UI (60mg)/0.6ml
- Substance:
- enoxaparin
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W67315010
- Concentration:
- 6000UI(60mg) / 0.6ml
- Pharmaceutical form:
- solution for injection in pre-filled syringe
- Quantity:
- 50
- Product type:
- Generic medicine
- Price:
- 706.87 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for enoxaparin
Concentrations available for enoxaparin
- 10000UI(100mg)/1.0ml
- 10000UI(100mg)/1ml
- 100mg/ml
- 12000UI(120mg)/0.8ml
- 15000UI(150mg)/1ml
- 2000ui anti-Xa/0.2ml
- 2000UI(20mg)/0.2ml
- 4000ui anti-Xa/0.4ml
- 4000UI(40mg)/0.4ml
- 6000ui anti-Xa/0.6ml
- 6000UI(60mg)/0.6ml
- 8000ui anti-Xa/0.8ml
- 8000UI(80mg)/0.8ml
Compensation lists for HEPAXANE 6000UI (60mg)/0.6ml Chemi
B - Sublist B with 50% discount from the reference price
- Price
- 706.87 RON
- Copayment
- 353.44 RON
- Patient
- 353.44 RON
NHP 10 (C2) - Replacement of renal function in patients with chronic renal failure
- Price
- 706.87 RON
- Copayment
- 706.87 RON
- Patient
- 0.00 RON
NHP 9.4 (C2) - Kidney transplant, combined kidney and pancreas transplant
- Price
- 706.87 RON
- Copayment
- 706.87 RON
- Patient
- 0.00 RON